PhenX - fasting C-peptide assay for residual beta cell function protocol 141201:-:Pt:
Patient:-:PhenX - CISMeF
PhenX - fasting C-peptide assay for residual beta cell function protocol 141201:-:Pt:
Patient:-:PhenXLOINC code
Preferred Label : PhenX - fasting C-peptide assay for residual beta cell function protocol 141201:-:Pt:
Patient:-:PhenX;
LOINC status : TRIAL;
LOINC long common name : PhenX - fasting C-peptide assay for residual beta cell function protocol 141201;
LOINC short name : Fasting C-peptide proto;
LOINC description : This protocol provides instructions for drawing, processing and storing blood according
to the National Health and Nutrition Examination Survey (NHANES) methods. As there
are no standard assays for C-peptide, the protocol also provides basic guidelines
to aid comparability among different studies. Although all three are valuable stand
alone measures and all should be collected if resources are available, the Diabetes
Working Group recommends that investigators prioritize Insulin 1st, C-peptide 2nd
and Proinsulin 3rd. This is because results from the Insulin bioassay can be combined
with results from Fasting Plasma Glucose bioassay to derive the homeostatic model
assessment (HOMA) of insulin resistance and pancreatic beta cell function. The Diabetes
Working Group notes that while it is not the preferred method, the C-peptide Assay
can be performed on individuals who have not met the fasting requirements.;